Literature DB >> 2983095

Isolation of polyomavirus mutants multiadapted to murine embryonal carcinoma cells.

F Melin, H Pinon, C Kress, D Blangy.   

Abstract

Polyomavirus mutants were isolated from PCC4 embryonal carcinoma cells infected with a variant strain of polyomavirus (ev 1001h) and were found to contain a tandem duplication overlapping the enhancers and the origin of replication. These mutants were able to infect several lines of embryonal carcinoma cells, including PCC4, F9, and LT1. The sequence and structure of one of these mutants are presented and compared with those of other PyEC PCC4 mutants previously described.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2983095      PMCID： PMC254719     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  21 in total

1.  Neoplastic differentiation: interaction of simian virus 40 and polyoma virus with murine teratocarcinoma cells in vitro.

Authors:  D E Swartzendruber; J M Lehman
Journal:  J Cell Physiol       Date:  1975-04       Impact factor: 6.384

2.  The development of teratomas from parthenogenetically activated ovarian mouse eggs.

Authors:  L C Stevens; D S Varnum
Journal:  Dev Biol       Date:  1974-04       Impact factor: 3.582

3.  Charon phages: safer derivatives of bacteriophage lambda for DNA cloning.

Authors:  F R Blattner; B G Williams; A E Blechl; K Denniston-Thompson; H E Faber; L Furlong; D J Grunwald; D O Kiefer; D D Moore; J W Schumm; E L Sheldon; O Smithies
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

4.  Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells.

Authors:  F K Fujimura; P L Deininger; T Friedmann; E Linney
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

5.  Expression of polyoma early functions in mouse embryonal carcinoma cells depends on sequence rearrangements in the beginning of the late region.

Authors:  M Katinka; M Yaniv; M Vasseur; D Blangy
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

6.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Isolation and characterization of polyoma virus mutants able to develop in embryonal carcinoma cells.

Authors:  M Vasseur; C Kress; N Montreau; D Blangy
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

8.  Isolation and characterization of polyoma host range mutants that replicate in nullipotential embryonal carcinoma cells.

Authors:  K Sekikawa; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

9.  Polyoma DNA sequences involved in control of viral gene expression in murine embryonal carcinoma cells.

Authors:  M Katinka; M Vasseur; N Montreau; M Yaniv; D Blangy
Journal:  Nature       Date:  1981-04-23       Impact factor: 49.962

10.  Construction and characterization of new cloning vehicles. V. Mobilization and coding properties of pBR322 and several deletion derivatives including pBR327 and pBR328.

Authors:  L Covarrubias; L Cervantes; A Covarrubias; X Soberón; I Vichido; A Blanco; Y M Kupersztoch-Portnoy; F Bolivar
Journal:  Gene       Date:  1981 Jan-Feb       Impact factor: 3.688
View more
  10 in total

1.  Host range specificity of polyomavirus EC mutants in mouse embryonal carcinoma and embryonal stem cells and preimplantation embryos.

Authors:  F Mélin; R Kemler; C Kress; H Pinon; D Blangy
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Nuclear activity from F9 embryonal carcinoma cells binding specifically to the enhancers of wild-type polyoma virus and PyEC mutant DNAs.

Authors:  F K Fujimura
Journal:  Nucleic Acids Res       Date:  1986-04-11       Impact factor: 16.971

3.  Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells.

Authors:  F Hilberg; C Stocking; W Ostertag; M Grez
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  A pancreas specificity results from the combination of polyomavirus and Moloney murine leukemia virus enhancer.

Authors:  R Rochford; B A Campbell; L P Villarreal
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

5.  Retroviral mutants efficiently expressed in embryonal carcinoma cells.

Authors:  T Franz; F Hilberg; B Seliger; C Stocking; W Ostertag
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

6.  Analysis of transcription factors binding to the duplicated PEA1 and PEA3 sites that are required for polyomavirus mutant expression in PCC4 embryonic carcinoma cells.

Authors:  J Y Nothias; R Weinmann; D Blangy; F Melin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Tissue specific phenotypes of polyomavirus A and B enhancer transpositions and duplications: positional and nonpositional effects on replication in lymphoid cells.

Authors:  B A Campbell; L P Villarreal
Journal:  Virus Genes       Date:  1987-11       Impact factor: 2.332

8.  Unique requirement for the PyF441 mutation for polyomavirus infection of F9 embryonal carcinoma cells.

Authors:  R W Tseng; T Williams; F K Fujimura
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  Common features of polyomavirus mutants selected on PCC4 embryonal carcinoma cells.

Authors:  F Melin; H Pinon; C Reiss; C Kress; N Montreau; D Blangy
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

10.  One cell-specific and three ubiquitous nuclear proteins bind in vitro to overlapping motifs in the domain B1 of the SV40 enhancer.

Authors:  J H Xiao; I Davidson; D Ferrandon; R Rosales; M Vigneron; M Macchi; F Ruffenach; P Chambon
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.